ID PBP_STAAU Reviewed; 670 AA. AC P07944; DT 01-AUG-1988, integrated into UniProtKB/Swiss-Prot. DT 01-AUG-1988, sequence version 1. DT 03-MAY-2023, entry version 104. DE RecName: Full=Beta-lactam-inducible penicillin-binding protein; GN Name=pbp; OS Staphylococcus aureus. OC Bacteria; Bacillota; Bacilli; Bacillales; Staphylococcaceae; OC Staphylococcus. OX NCBI_TaxID=1280; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=3305073; DOI=10.1016/0014-5793(87)80373-3; RA Song M.D., Wachi M., Doi M., Ishino F., Matsuhashi M.; RT "Evolution of an inducible penicillin-target protein in methicillin- RT resistant Staphylococcus aureus by gene fusion."; RL FEBS Lett. 221:167-171(1987). CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass membrane CC protein {ECO:0000305}. CC -!- INDUCTION: In the presence of beta-lactam antibiotics, MRSA cells CC produce this unique PBP in excessively large amounts and can still CC proliferate, while all the normal PBPs are inactivated (reversible CC switching ability of PBP formation). CC -!- MISCELLANEOUS: PBP has extremely low affinity to penicillin and most CC other beta-lactam antibiotics. CC -!- SIMILARITY: Belongs to the transpeptidase family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; Y00688; CAA68684.1; -; Genomic_DNA. DR AlphaFoldDB; P07944; -. DR SMR; P07944; -. DR DrugBank; DB02443; Methicillin Acyl-Serine. DR DrugBank; DB04041; Nitrocefin Acyl-Serine. DR DrugBank; DB02968; Penicillin G Acyl-Serine. DR DrugCentral; P07944; -. DR MEROPS; X52.001; -. DR GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell. DR GO; GO:0008658; F:penicillin binding; IEA:InterPro. DR GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW. DR GO; GO:0051301; P:cell division; IEA:UniProtKB-KW. DR GO; GO:0071555; P:cell wall organization; IEA:UniProtKB-KW. DR GO; GO:0009252; P:peptidoglycan biosynthetic process; IEA:UniProtKB-KW. DR GO; GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW. DR GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW. DR Gene3D; 3.40.710.10; DD-peptidase/beta-lactamase superfamily; 1. DR Gene3D; 3.90.1310.10; Penicillin-binding protein 2a (Domain 2); 1. DR InterPro; IPR012338; Beta-lactam/transpept-like. DR InterPro; IPR007887; MecA_N. DR InterPro; IPR032710; NTF2-like_dom_sf. DR InterPro; IPR005311; PBP_dimer. DR InterPro; IPR036138; PBP_dimer_sf. DR InterPro; IPR001460; PCN-bd_Tpept. DR PANTHER; PTHR30627:SF25; PENICILLIN-BINDING PROTEIN 3; 1. DR PANTHER; PTHR30627; PEPTIDOGLYCAN D,D-TRANSPEPTIDASE; 1. DR Pfam; PF05223; MecA_N; 1. DR Pfam; PF03717; PBP_dimer; 1. DR Pfam; PF00905; Transpeptidase; 1. DR SUPFAM; SSF56601; beta-lactamase/transpeptidase-like; 1. DR SUPFAM; SSF54427; NTF2-like; 1. DR SUPFAM; SSF56519; Penicillin binding protein dimerisation domain; 1. PE 2: Evidence at transcript level; KW Antibiotic resistance; Cell cycle; Cell division; Cell membrane; KW Cell shape; Cell wall biogenesis/degradation; Membrane; KW Peptidoglycan synthesis; Transmembrane; Transmembrane helix. FT CHAIN 1..670 FT /note="Beta-lactam-inducible penicillin-binding protein" FT /id="PRO_0000195443" FT TRANSMEM 4..24 FT /note="Helical" FT /evidence="ECO:0000255" FT ACT_SITE 405 FT /note="Acyl-ester intermediate" FT /evidence="ECO:0000250|UniProtKB:P0AD65" FT BINDING 25 FT /ligand="a penicillin" FT /ligand_id="ChEBI:CHEBI:51356" FT /evidence="ECO:0000305" FT BINDING 405 FT /ligand="a penicillin" FT /ligand_id="ChEBI:CHEBI:51356" FT /evidence="ECO:0000305" SQ SEQUENCE 670 AA; 76463 MW; 2DAA414D35DA993A CRC64; MKKIKIVPLI LIVVVVGFGI YFYASKDKEI NNTIDAIEDK NFKQVYKDSS YISKSDNGEV EMTERPIKIY NSLGVKDINI QDRKIKKVSK NKKRVDAQYK IKTNYGNIDR NVQFNFVKED GMWKLDWDHS VIIPGMQKDQ SIHIENLKSE RGKILDRNNV ELANTGTHMR LGIVPKNVSK KDYKAIAKEL SISEDYINNK WIKIGYKMIP SFHFKTVKKM DEYLSDFAKK FHLTTNETES RNYPLGKATS HLLGYVGPIN SEELKQKEYK GYKDDAVIGK KGLEKLYDKK LQHEDGYRVT IVRVDDNSNT IAHTLIEKKK KDGKDIQLTI DAKVQKSIYN NMKNDYGSGT AIHPQTGELL ALVSTPSYDV YPFMYGMSNE EYNKLTEDKK EPLLNKFQIT TSPGSTQKIL TAMIGLNNKT LDDKTSYKID GKGWQKDKSW GGYNVTRYEV VNGNIDLKQA IESSDNIFFA RVALELGSKK FEKGMKKLGV GEDIPSDYPF YNAQISNKNL DNEILLADSG YGQGEILINP VQILSIYSAL ENNGNINAPH LLKDTKNKVW KKNIISKENI NLLNDGMQQV VNKTHKEDIY RSYANLIGKS GTAELKMKQG ETGRQIGWFI SYDKDNPNMM MAINVKDVQD KGMASYNAKI SGKVYDELYE NGNKKYDIDE //